The Stopping the Transmission of Opioids to the Next Generation tool allows clinicians treating women of childbearing age with opioid use disorder to estimate risks associated with pregnancies in this patient population.
Dr Cosio presented results from a preliminary study examining the prevalence of mental health disorders in veterans with chronic pain.
The prevalence of opioid use disorder rose in women delivering at hospitals across 28 US states and the District of Columbia between 1999 and 2014, with quadrupling at the national level during this period.
Causes of death in the year after a nonfatal opioid overdose were often related to substance use disorders, as well as to a range of mental health and medical conditions.
Few of the individuals who experience an opioid-related overdose had received treatment for opioid use disorder.
The US Food and Drug Administration has issued warnings to 3 companies selling kratom-containing products with unsubstantiated claims regarding their effectiveness in conditions that include opioid withdrawal and addiction and chronic pain.
April 28, 2018 is National Prescription Drug Take Back Day.
Katie Burk, MPH, presented measures undertaken by the city of San Francisco to provide integrated responses to the concurrent HIV/HCV and opioid public health epidemics.
Package inserts of opioid analgesics may not consistently provide information regarding safe drug storage and/or disposal.
Synthetic cannabinoid use may result in shorter hospital stays and reduced antipsychotic doses in patients with bipolar disorder.
